Consumer Health Testing Market Grows Amidst Regulatory Concerns

The market for at-home health tests targeted at consumers is experiencing rapid growth, but the sector's quick development is shadowed by unclear regulatory frameworks and a lack of scientific evidence for many products.

Amidst piles of collection kits and instruction booklets, many consumers are increasingly conducting at-home tests to gain insights into their biological age, gut microbiome, or stress levels. Additionally, tests for heart health, hormones, and metabolism have emerged on the market. According to Precedence Research, the home diagnostics market was valued at $6.9 billion last year and is projected to nearly double by 2035.

While some companies are developing tests that address critical needs in potentially revolutionary ways, such as Visby Medical's chlamydia, gonorrhea, and trichomoniasis tests or Teal Health's cervical precancer screening test, the majority of companies advertising on social media focus on preventive health and wellness. These companies often bypass the regulatory requirements set by the FDA for clinical diagnostics.

Industry experts point out that while the results may feel useful, they are more akin to health "infotainment." There is also concern that companies may try to hook consumers into monthly subscriptions for vitamins, supplements, and coaching services. Jenny Rooke, founder and managing director of the biotechnology venture firm Genoa Ventures, warns that "infotainment" companies have an incentive to make increasingly stronger claims to appear more valuable.

What is potentially most confusing for consumers is how science and "snake oil," clinical tests and curiosity tests, commingle. Online stores, such as Everlywell, offer both health services and tests with vaguer promises of "potential health associations," which can lead to confusion and misinterpretations.